Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SensoDetect - Notification of patent granted in the United States

SensoDetect has been informed by AWA Patent that the US Patent Office has granted patent application from SensoDetect regarding "BRAIN RESPONSE STATE".SensoDetect representative for patents and IPO, AWA patent, is assisting with the patent portfolio, which today consists of 4 families and where BRAINSTEM RESPONSE STATE is one of these. Brainstem response application includes both audio stimuli and the analytical part of which SensoDetects technology is based and is therefore an important part of patent protection. Patents in the United States are valid for 20 years from the date of

Metsä Group’s bioproduct mill has produced more than 1 million tonnes of pulp, reaching its full production capacity

Metsä Group press release 13 August 2018Metsä Group’s next-generation bioproduct mill in Äänekoski reached its nominal capacity in August 2018, according to plan. This makes Metsä Group the world’s largest producer of softwood market pulp. The bioproduct mill produced its millionth tonne of pulp on 8 August 2018. The bioproduct mill was started up on 15 August 2017, on schedule and within budget. The start-up phase progressed in line with the target curve. The bioproduct mill produces 1.3 million tonnes of high-quality softwood and birch pulp annually, in addition to other bioproducts,

Appointment of Chief Medical Officer at Moberg Pharma

STOCKHOLM, August 13th, 2018, Moberg Pharma AB (OMX: MOB) announces the appointment of Shaw Sorooshian as Vice President and Chief Medical Officer of Moberg Pharma. Shaw Sorooshian will during the fall be joining the management team at Moberg Pharma coming from a previous position as Senior Director Global Medical Affairs at Sobi AB.Moberg Pharma is pleased to announce the appointment of Shaw Sorooshian as new Vice President and Chief Medical Officer at Moberg Pharma. Shaw Sorooshian will be replacing Kjell Rensfeldt in the management team, bringing extensive experience from his previous

Yggdrasil to enter Czech Republic with Tipsport gaming deal

Yggdrasil, a Cherry AB (publ) – STO: CHER-B.ST – subsidiary, has signed an agreement with Tipsport, the largest operator in the Czech Republic. Yggdrasil will offer its portfolio of innovative, high-quality casino games in this regulated market for the first time.Tipsport is the Czech Republic’s largest betting and gaming brands with more than 1,000 retail outlets and a rapidly growing online offering that will now feature some of Yggdrasil’s smash-hit slot games, including latest releases Vikings Go To Hell and Tut’s Twister. Tipsport will also use Yggdrasil’s unique in-game promotional

Kährs Group acquires Ehrenborg

Kährs Group, a Swedish Europe-leading manufacturer of wood flooring and PVC-free resilient flooring, has acquired flooring distributor Ehrenborg & Co, which is a leader in the Swedish flooring market for public areas. Ehrenborg also operates in the rest of the Nordic countries as well as in several export markets.Through the acquisition of Ehrenborg, Kährs Group strengthens its sales and distribution to customers in commercial projects and broadens its product portfolio with new products in project sales. The companies have been cooperating for a long time as Ehrenborg is responsible for

Reminder: Welcome to Elekta’s Capital Markets Day in Stockholm on September 27, 2018

STOCKHOLM, August 13, 2018 – Elekta (EKTA-B.ST) invites equity analysts, investors and media representatives to Elekta’s Capital Markets Day on September 27 at Stockholm Waterfront Congress Centre. A light lunch will be provided from 12:00. Presentations will start at 13:00 CET and will end at approximately 16:30 CET.Speakers at the event will include Dr. Richard Hausmann, President and CEO, Gustaf Salford, CFO, and other members of Elekta’s management team. To attend, please register through the following link: http://www.cvent.com/d/5gq38r no later than August 31, 2018. It will also

Valmet to upgrade the Ahlstrom-Munksjö Billingsfors pulp mill in Sweden

Valmet Oyj's press release on August 13, 2018 at 11:00 a.m. EET Valmet has been chosen as a supplier by Ahlstrom-Munksjö for the upgrade of the recovery boiler and surrounding systems in the Billingsfors mill in Sweden. The main objective is to increase the capacity of the recovery boiler. The upgrade will also result in a better boiler availability and environmental performance. The order was included in Valmet's second quarter 2018 orders received. The value of this kind of order is typically above EUR 10 million. The upgraded recovery boiler is planned to be started in the second

INVISIO’s headset used in helicopter stunts in Mission: Impossible – Fallout

In the latest Mission: Impossible movie, Tom Cruise did his helicopter stunt scenes using an INVISIO headset to secure clear communications in loud, mission-critical situations.  The INVISIO equipment was chosen for clear, quality communication and safety reasons. Flying a helicopter takes a lot of skills and each piece of the equipment must be carefully selected and inspected. One of the primary reasons for clear communication methods in loud environments is the overall safety of the performer.“It is very well known that Tom Cruise performs his own movie stunts and we are proud to

#18-1422 Recalculation of reference value for certain instruments with Bayer AG as underlying security

The reference value for certain certificates with Bayer AG as underlying has been recalculated in accordance with the instruments final terms. This applies to the following instruments: Symbol: BULL BAYER X10 C Symbol: BULL BAYN X10 V Symbol: BULL BAYN X10 VON Symbol: BULL BAYN X8 VONThe instruments will be traded under observation for the duration of this trading day. For more information concerning the recalculation, please contact the issuer of the affected instrument. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8

Hemfosa seeks approval from bondholders to a potential distribution of Nyfosa

Hemfosa Fastigheter AB (“Hemfosa”) today announces that it is, through a written procedure, soliciting approval from holders of its bonds with ISIN SE0009357403 and SE0009664337 (the “Bonds”) to amend the terms and conditions of the Bonds in relation to a potential distribution of the shares in its subsidiary Nyfosa. The solicitation procedure is a further step to enable for a distribution by Hemfosa of the shares in Nyfosa during the fourth quarter of 2018.Hemfosa has requested that Nordic Trustee & Agency AB (publ), acting in its capacity as agent (the “Agent”) for the holder of Bonds,

Cantargia presents update on the CANFOUR clinical trial and phase IIa preparations

· 15 patients treated and CAN04 showed a good safety profile · A few more patients to be included to establish maximum tolerated or recommended dose · The phase IIa part of the study to start in Q4 2018 Cantargia AB today announced the status of the ongoing phase I/IIa clinical trial CANFOUR investigating the lead compound CAN04 (nidanilimab) and further information on the phase IIa part of the trial.So far, 15 patients have received therapy in the phase I safety part of the study, and generally the immuno-oncology antibody CAN04, targeting IL1RAP, has been well tolerated. Notably,

Nytt navn fra og med / New name from 13.08.2018

Axactor AB (publ) endrer selskapets navn til Axactor SE. Se melding fra selskapet 10.08.2018. Selskapet vil fra og med 13.08.2018 være notert på Oslo Børs med nytt navn Axactor SE. ISIN, ticker og instrument ID er uforandret. Axactor AB (publ)changes the company name Axactor SE. See announcement from the company 10.08.2018. The company will be listed on Oslo Børs with the new name Axactor SE from 13.08.2018. ISIN number, ticker and instrument ID remains unchanged.

Self Storage Group ASA: Invitation to presentation of second-quarter 2018 results

Self Storage Group ASA will release its financial results for second quarter 2018, on Wednesday 15 August 2018.The results will be presented at 08:00 a.m. (CET) at Arctic offices, Haakon VIIs gate 5, Oslo. The presentation will be held by CEO Fabian Søbak and CFO Cecilie Hekneby.Language: NorwegianWebcast: The presentation will be broadcasted live on https://www.selfstoragegroup.no/web-cast/If you want to attend the presentation, please register by email to events@arctic.com.The financial report and presentation will be made available under the company's ticker "SSG" on www.

Aitolampi Maiden Mineral Resource Estimate

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations ("MAR") (EU) No. 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.  For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is being made on behalf of Kurt Budge, Chief Executive Officer.  13 August 2018 Beowulf Mining plc (“Beowulf” or the “Company”) Aitolampi Maiden Mineral Resource Estimate Beowulf (AIM:

Mycronic lands order for two FPS6100 mask writers

Mycronic has signed an agreement with a customer in Asia for two FPS mask writers for the multi-purpose segment. The order is for the FPS6100, which was introduced about two years ago, and the order value for each system is within the normal range of USD 2-5 million per system depending on system specifications. Delivery of the first system is planned for the first quarter of 2019 and the second for the fourth quarter of the same year. Within the multi-purpose segment, uses of photomasks include electronic packaging, touch-screens and MEMS (Micro-Electro-Mechanical Systems), and the

Calliditas Therapeutics to host conference call to provide Q2 2018 Business Update

On August 16, 2018, at 07:00am CEST, Calliditas Therapeutics (“Calliditas”) will publish its interim report for the second quarter of 2018. All interested parties are invited to participate in a telephone conference, which will include a presentation, on the same day at 10:00am CEST. The event will be hosted by the company’s CEO and President, Renée Aguiar-Lucander, and CFO Fredrik Johansson. The presentation will be held in English.Slides used in the presentation will be live on the company’s website during the call under Financial Reports and Presentations and will also be made available

Rottneros AB (publ) gives an update on the pulp wood situation and corrects an error in the interim report January-June 2018

As reported in the Rottneros interim report January-June 2018, the supply of pulp wood has been negatively impacted by the extreme weather and subsequent drought in Sweden. Rottneros has increased the import volumes to its pulp mills through its subsidiary SIA Rottneros Baltic in Latvia, in order to minimise the effects on pulp deliveries to its customers. The import from the Baltics is certified for traceability and Rottneros has control over the origin of the pulp wood. Rottneros is working continuously with its suppliers to secure the supply of pulp wood and to estimate the potential

Q2 2018: Regained business momentum and strong margin improvement

Highlights and significant events in the second quarter• Net sales increase from MSEK 119 to MSEK 153 compared to the previous quarter and improvement of EBITDA margin quarter-over-quarter from 14% to 28%• Market introduction of Probi® Osteo, the new premium concept in bone health and osteoporosis, at Probi’s 6th Annual Partner Conference• Probi receives a 2018 NutraIngredients Award for its promising research results on the prevention of gluten intolerance in children Financial overview MSEK   H1 2018   H1 2017   Full-year 2017

There are no items matching the current filter
There are no more items matching the current filter
Back to top